Suyash Prasad
Corporate Officer/Principal chez The Royal College of Physicians
Profil
Suyash Prasad is a Member at The Royal College of Physicians and The Royal College of Paediatrics & Child Health.
He is also the Principal at Dr. Prasad Consulting LLC since 2019.
Previously, he worked as the Senior Group Medical Director-Development Sciences at BioMarin Pharmaceutical, Inc. from 2010 to 2014.
He was also the Director-Global Medical Affairs at Genzyme Corp.
from 2009 to 2010.
Additionally, he served as the Chief Medical Officer & Senior Vice President at Astellas Gene Therapies, Inc. from 2014 to 2019.
Currently, he is the Chief Medical Officer at Taysha Gene Therapies, Inc. from 2022 to 2023.
Dr. Prasad holds a doctorate degree from Newcastle University and a graduate degree from King's College London.
Postes actifs de Suyash Prasad
Sociétés | Poste | Début |
---|---|---|
The Royal College of Physicians | Corporate Officer/Principal | - |
The Royal College of Paediatrics & Child Health | Corporate Officer/Principal | - |
Suyash Prasad Consulting LLC | Corporate Officer/Principal | 01/10/2019 |
Anciens postes connus de Suyash Prasad
Sociétés | Poste | Fin |
---|---|---|
TAYSHA GENE THERAPIES, INC. | Directeur Technique/Scientifique/R&D | 12/01/2023 |
AUDENTES THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 30/06/2019 |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/02/2014 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/12/2010 |
National Pku Alliance | Directeur/Membre du Conseil | - |
Formation de Suyash Prasad
Newcastle University | Doctorate Degree |
King's College London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
TAYSHA GENE THERAPIES, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
National Pku Alliance | |
Suyash Prasad Consulting LLC |